The abstract is read at the publisher; the summary is JClub's.
FDG-PET in giant cell arteritis showed active vasculitis in 28 of 51 patients at baseline, but PET activity was not linked to clinical symptoms or acute phase reactants.
- Why it matters: Clinical and laboratory measures may not reflect vascular inflammation consistently, creating uncertainty about how well FDG-PET aligns with disease activity during treatment and flare.
- What they did: In an international multicenter RCT of new-onset or relapsing GCA, FDG-PET was done at baseline and repeated at flare or week 52, with two-reader active/inactive interpretation and PET Vascular Activity Score compared to clinical and lab measures.
- The result: PET was active in 17 of 21 during clinical flare and in 14 of 20 at week 52, and some patients had persistently active (n = 21) or inactive (n = 9) scans regardless of clinical assessment.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.